.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Citi
Medtronic
Fuji
AstraZeneca
Chubb
Accenture
Healthtrust
Novartis

Generated: September 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE; LIXISENATIDE

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us
SOLIQUA 100/33
insulin glargine; lixisenatide
SOLUTION;SUBCUTANEOUS208673NDASanofi-Aventis U.S. LLC0024-5761-055 SYRINGE in 1 CARTON (0024-5761-05) > 3 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Express Scripts
AstraZeneca
Cantor Fitzgerald
UBS
Deloitte
Daiichi Sankyo
Baxter
Healthtrust
Cerilliant

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot